Kenneth Abramowitz is a Managing General Partner and co-founder of NGN Capital, a $450 million worldwide healthcare venture capital fund. He joined NGN from The Carlyle Group in New York where he was Managing Director, focused on U.S. buyout opportunities in the healthcare industry. Prior to Carlyle, he was a healthcare analyst for Sanford C. Bernstein & Co. for 23 years. He was awarded the Number 1 analyst in Medical Devices and/or Services for 15 years by the Institutional Investor magazine, which also placed him in the Wall Street Analyst Hall of Fame in 2009 with a rank of 15 out of 15,000 analysts. Ken has published several notable studies on healthcare service companies, major medical mergers and cardiovascular device innovation. He currently serves on the Board of Directors of Cardiovalve and Cerapedics. He also serves in leadership positions on a variety of non-profit boards.